RBII Stock Overview
Develops and manufactures topical and oral pharmaceutical products, including medical marijuana products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rising BioSciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.80% |
| 5 Year Change | -99.97% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| RBII | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.9% | -0.5% |
| 1Y | 0% | 20.3% | 24.2% |
Return vs Industry: RBII underperformed the US Pharmaceuticals industry which returned 20.3% over the past year.
Return vs Market: RBII underperformed the US Market which returned 24.2% over the past year.
Price Volatility
| RBII volatility | |
|---|---|
| RBII Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: RBII has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RBII's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.risingbiosciences.org |
Rising BioSciences, Inc. develops and manufactures topical and oral pharmaceutical products, including medical marijuana products. The company is based in Sheridan, Wyoming.
Rising BioSciences, Inc. Fundamentals Summary
| RBII fundamental statistics | |
|---|---|
| Market cap | US$1.06k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs RBII overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RBII income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RBII perform over the long term?
See historical performance and comparison